1. Home
  2. MLEC vs BMRA Comparison

MLEC vs BMRA Comparison

Compare MLEC & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Moolec Science SA

MLEC

Moolec Science SA

HOLD

Current Price

$7.86

Market Cap

6.5M

Sector

Finance

ML Signal

HOLD

Logo Biomerica Inc.

BMRA

Biomerica Inc.

N/A

Current Price

$2.41

Market Cap

7.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MLEC
BMRA
Founded
2008
1971
Country
Cayman Islands
United States
Employees
72
54
Industry
Blank Checks
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
7.5M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
MLEC
BMRA
Price
$7.86
$2.41
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
25.5K
15.1K
Earning Date
05-12-2026
04-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$5,311,000.00
Revenue This Year
$20.42
N/A
Revenue Next Year
$30.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.21
$1.87
52 Week High
$23.22
$4.60

Technical Indicators

Market Signals
Indicator
MLEC
BMRA
Relative Strength Index (RSI) 46.48 56.85
Support Level $7.18 $2.33
Resistance Level $11.48 $2.40
Average True Range (ATR) 0.85 0.13
MACD -0.12 0.01
Stochastic Oscillator 14.34 70.12

Price Performance

Historical Comparison
MLEC
BMRA

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

Share on Social Networks: